Nick Lloyd Webber, Son of Composer Andrew Lloyd Webber, Dies at 43
Nick Lloyd Webber, the son of composer and musical theater impresario, Andrew Lloyd Webber, died Saturday after suffering from gastric cancer, his father announced Saturday. He was 43. “I am shattered to have to announce that my beloved elder son Nick died a few hours ago in Basingstoke Hospital.…#nicklloydwebber #andrewlloydwebber #basingstokehospital (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2023 Category: Consumer Health News Source Type: news
Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer
(MedPage Today) -- Zolbetuximab plus capecitabine and oxaliplatin (CAPOX) improved survival outcomes in patients with Claudin (CLDN)18.2-positive, HER2-negative, locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinomas... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 24, 2023 Category: Gastroenterology Source Type: news
Six warning signs of stomach cancer revealed
There are around 4,200 stomach cancer deaths in the UK every year, says Cancer Research Indigestion and feeling sick are both warning signs of stomach cancer, experts say. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2023 Category: Consumer Health News Source Type: news
Bile Duct Cancer: Awareness, Funding Needed to Fight This Silent Killer
MONDAY, March 20, 2023 -- Lawyer, entrepreneur and avid athlete Mark Clements participated in the 2005 St. George Marathon in Utah, but ongoing stomach pains made finishing the event a struggle.“He was having some stomach pain,”... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 20, 2023 Category: General Medicine Source Type: news
Andrew Lloyd Webber to Miss ‘Bad Cinderella’ Broadway Opening Due to Son’s Critical Illness
Andrew Lloyd Webber has announced that he will be absent from the opening night of his new Broadway musical Bad Cinderella because his eldest son is “critically ill” with gastric cancer. The Phantom of the Opera composer shared a statement with The Hollywood Reporter on Saturday (March 18),…#andrewlloydwebber #broadway #badcinderella #opera #hollywoodreporter #nicholaslloydwebber #charlesiii #coronation #newyorkcitys #imperialtheatre (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2023 Category: Consumer Health News Source Type: news
Andrew Lloyd Webber Says His Son Is Critically Ill, Will Miss ‘Bad Cinderella’ Broadway Opening
The Phantom of the Opera composer Andrew Lloyd Webber revealed his eldest son, Nicholas Lloyd Webber, is critically ill with gastric cancer. “I am absolutely devastated to say that my eldest son Nick is critically ill,” the Oscar-winning composer shared in a statement on Saturday. “As my friends…#phantom #opera #andrewlloydwebber #nicholaslloydwebber #nick #nicholas #records #lastbus #grammy #broadway (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2023 Category: Consumer Health News Source Type: news
Laparoscopy, Surgery in a Draw for Gastric Cancer Survival
(MedPage Today) -- Relapse-free survival (RFS) data at 5 years showed that laparoscopy-assisted distal gastrectomy (LADG) was noninferior to open distal gastrectomy (ODG) in locally advanced gastric cancer, according to a phase II/III randomized... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 15, 2023 Category: Gastroenterology Source Type: news
The supplement that may raise the risk of stomach cancer after ‘many years of use’
The risk of cancer may be greater for certain groups of individuals taking the supplement, research has shown. (Source: Daily Express - Health)
Source: Daily Express - Health - March 6, 2023 Category: Consumer Health News Source Type: news
New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Fertility Clinic Sued for Using Embryo With Deadly Cancer Gene Fertility Clinic Sued for Using Embryo With Deadly Cancer Gene
A California couple sued a Pasadena-based fertility clinic, saying it allegedly implanted an embryo carrying a rare gene that causes deadly stomach cancer and then falsified records to cover up its mistake.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 2, 2023 Category: Surgery Tags: Ob/Gyn & Women ' s Health News Source Type: news
For People with Eating Disorders, the Buzz About Ozempic Is a Nightmare
While scrolling Twitter late one recent night, Nylah Burton, a 27-year-old writer in Chicago, clicked on an article about Ozempic, the diabetes drug that’s increasingly prescribed off-label for people who want to lose weight. Only when she hit the website’s paywall did she pause to realize she actually had no desire to read the article.
Burton struggled with disordered eating for more than a decade, starting at age 11, and says media portrayals of thinness and extreme diets contributed to her eating issues. Her eating habits have been stable for the last year, and Burton felt no need to challenge that progress ...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Alembic Pharma gets USFDA nod to market generic cancer drug
Docetaxel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and squamous cell carcinoma of head and neck. According to IQVIA data, Docetaxel injection has an estimated market size of USD 11 million in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2023 Category: Pharmaceuticals Source Type: news
Janssen Receives Positive CHMP Opinion for AKEEGA ® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer
BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorisation for AKEEGA® (niraparib and AA), in the form of a DAT, given with P or prednisolone, for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated.[1]Niraparib is a highly selective poly adenosine diphosphate-ribose polymerase (PARP) inhibi...
Source: Johnson and Johnson - February 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
AstraZeneca enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate
AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targeting Claudin 18.2, a promising therapeutic target in gastric cancer. Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture and commercialisation of CMG901 globally. (Source: World Pharma News)
Source: World Pharma News - February 23, 2023 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
CEUS better than MRI for diagnosing liver, kidney tumors
Contrast-enhanced ultrasound (CEUS) is better than MRI for diagnosing particula...Read more on AuntMinnie.comRelated Reading:
Modified CEUS method does well in categorizing liver lesions
CEUS bests CT in early gastric cancer staging
CEUS-guided biopsy shows superiority in liver imaging
AIUM: CEUS shows promise for pediatric patients
CEUS helps identify lymph nodes in breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2023 Category: Radiology Source Type: news
